Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.51 HKD | -1.92% | -3.77% | -22.73% |
Apr. 22 | Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug | MT |
Apr. 17 | Future Data Group Limited Announces Changes to its Board | CI |
Sales 2021 | 721M 92.15M | Sales 2022 | 618M 78.99M | Capitalization | 156M 19.95M |
---|---|---|---|---|---|
Net income 2021 | 7M 895K | Net income 2022 | -3M -384K | EV / Sales 2021 | 0.1 x |
Net cash position 2021 | 35.36M 4.52M | Net cash position 2022 | 56.95M 7.28M | EV / Sales 2022 | 0.16 x |
P/E ratio 2021 |
14.9
x | P/E ratio 2022 |
-50.3
x | Employees | 243 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.53% |
1 day | -1.92% | ||
1 week | -3.77% | ||
Current month | +18.60% | ||
1 month | +14.61% | ||
3 months | -5.56% | ||
6 months | -38.55% | ||
Current year | -22.73% |
Managers | Title | Age | Since |
---|---|---|---|
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Yuk Kan Lo
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xia Tao
CHM | Chairman | 50 | 22-10-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.51 | -1.92% | 895 000 |
24-04-29 | 0.52 | 0.00% | 650,000 |
24-04-26 | 0.52 | 0.00% | 785,000 |
24-04-25 | 0.52 | 0.00% | 735,000 |
24-04-24 | 0.52 | -1.89% | 780,000 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.73% | 36.32M | |
-7.12% | 31.67B | |
-6.53% | 8.93B | |
+8.31% | 7.51B | |
+3.85% | 4.95B | |
-44.61% | 4.54B | |
+12.57% | 3B | |
+10.17% | 2.45B | |
-10.53% | 2.44B | |
-10.97% | 2.17B |
- Stock Market
- Equities
- 8229 Stock